Your Partner in Health for Pregnant and Lactating Patients with Cardiovascular Disease
MotherToBaby supports cardiologists and lipidologists in managing cardiovascular disease during pregnancy and while breastfeeding. We understand the challenges that you face when deciding on treatment courses when your patient is pregnant or breastfeeding. Care of people who are pregnant and/or lactating with serious conditions like hypertension, hypercholesterolemia, or ASCVD is further complicated by the physiological changes of pregnancy that may alter treatment needs throughout the course of pregnancy. Our resources will help you weigh the risks and benefits to both your patient who is pregnant and their baby as you determine a treatment plan that maximizes disease management and minimizes maternal and fetal/infant risk.
We are also dedicated to furthering the information and understanding of medication safety in pregnancy through our observational MotherToBaby Pregnancy Studies, and we are proud to lead more than half of all Food and Drug Administration (FDA)-mandated pregnancy registries conducted in the U.S. MotherToBaby Pregnancy Studies are rigorously designed cohort studies that aim to provide critically needed product safety information – and your patient referrals make all the difference. If you have cardiac or lipid patients with comorbid conditions like COVID-19, asthma, rheumatoid arthritis, or Crohn’s disease, please consider referring them to our research studies. With your referral, you are helping us generate data that will lead to improved product safety information in pregnancy, thereby providing patients and health providers with the evidence they need to make more informed treatment decisions.
Heart disease and stroke are the leading cause of pregnancy-related death before, during, and up to a year after delivery.
— Centers for Disease Control and Prevention (CDC)
Explore how we can help you and your pregnant and breastfeeding patients by providing no-cost exposure risk assessments, patient education materials, and more.
Related Fact Sheets
- ACE Inhibitors
- Alirocumab (Praluent®)
- Atenolol (Tenormin®)
- Clonidine
- Clopidogrel (Plavix®)
- Evolocumab (Repatha®)
- Guanfacine (Intuniv®, Tenex®)
- High Cholesterol
- Insulin Aspart (NovoLog®)
- Labetalol
- Lisinopril
- Losartan (Cozaar®)
- Low Dose Aspirin
- Metoprolol
- Nifedipine (Procardia®)
- Paternal Exposures
- Propranolol
- Regular Strength Aspirin
- Statins
- Verapamil
Exposure Information
We provide no-cost, evidence-based info on exposures during pregnancy or breastfeeding by phone, text, email, and chat.
Request Materials
We offer free patient education materials and provider resources for our information service and pregnancy studies.
LactRx App
Download our LactRx app for on-the-go access to the Library of Medicine’s LactMed database for current information on cardiology and lipidology medications as well as other drugs and vaccinations to which breastfeeding mothers may be exposed.
Partners
- The FH Foundation
- The Foundation of the National Lipid Association (NLA)
- PCNA
- Society for Maternal-Fetal Medicine
- Society for Birth Defects Research & Prevention
- Patient Education Genius
- MyHealthTeams
- PatientsLikeMe
- The Mighty
FAQs
Get answers to the most frequently asked questions about our information service and pregnancy studies.
Stay In Touch
Our e-Newsletter brings you the latest information, news, and resources from the experts at MotherToBaby.
Refer a Patient
Need to give your patient a personalized assessment on an exposure risk or connect them to our pregnancy studies?